Date: 2017-12-04
Type of information: Nomination
Compound: vice-president
Company: Cellectis (France)
Therapeutic area: Cancer - Oncology - Rare diseases
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On December 4, 2017, Cellectis announced that the
company has appointed Elsy Boglioli to the role of Executive Vice President, Strategy and Corporate Development. Ms. Boglioli’s responsibilities include directing the long term strategy and current business priorities of Cellectis to ensure that the overall mission of the company is fulfilled. Ms. Boglioli joins Cellectis from Boston Consulting Group (BCG), where she served as Partner and Managing Director, and leader of BCG’s biotech-focused business in Europe.
Ms. Boglioli has far-reaching expertise within the pharma and medtech industries, focusing on everything from corporate strategy and M&A to research. At BCG, she was also a member of the global biopharma leadership team and global strategy practice management team and served as regional head of the strategy practice for Europe. Ms. Boglioli graduated from Ecole Polytechnique in Paris, France and holds a master’s degree in economy and management from Pompeu Fabra University in Barcelona.
Financial terms:
Latest news:
Is general: Yes
